Live feed07:00:00·117dPRReleasevia QuantisnowCrescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid TumorsByQuantisnow·Wall Street's wire, on your screen.CBIO· Crescent Biopharma Inc.Health Care
